Lupin Share Price Target 2024, 2025, 2030, 2040, 2050

Byshareprice-target.com

Lupin is one of the largest Indian pharmaceutical companies which makes and sells a variety of medicines at very affordable prices. The company is well known for its medicine for diabetes, heart problems, lung conditions, and mental health.

https://www.lupin.com

The company do business in the country and it supplies its product to the outside of the country.

What is Lupin Ltd NSE: LUPIN?

Lupin Limited is an Indian company that makes a wide range of medicines including, biosimilars, generic drugs, and over-the-counter (OTC) medicines in over 100 countries like the U.S., India, South Africa, Asia, Latin America, Europe, and the Middle East. The company is well-known for its medicines for diabetes, heart problems, and breathing issues, as well as treatments for infections, stomach problems, and brain health. It was established in 1968 by Desh Bandhu Gupta.

Lupin Share Price Target Tomorrow

The stock is currently in an uptrend but this rise seems to be getting weaker. The price is below the important level of 2216 on the chart. If it stays below this level, the stock might fall in the short term. For tomorrow, the stock may be moved sideways as there is no big trade by the company. It’s a good idea to wait and see how it performs in the first half of the day. If it shows weakness later in the day, this trend might continue. If it shows strength, the trend could continue in the next trading session.

Track all markets on TradingView

The price would be between ₹2198 to ₹2275 in 2024.

YearMinimum target (Rs)Maximum target (Rs)
2024-28+35

Lupin Share Price Target 2024

The company began with many challenges. The founder started the company by borrowing ₹5,000 from his wife, and later it did very well. The company has grown very well. It does business outside the country too. In the last 15 years, it has expanded to over 70 countries. Experts in India think that by 2024, Lupin’s share price target would be ₹2600.

In 2024, its share price would be between ₹1300 to ₹2600.

YearMinimum Price (Rs)Maximum Price (Rs)
202413002600
MonthMinimum Price (Rs)Maximum Price (Rs)
January13001420
February14841692
March15441696
April15341677
May15501720
June14801692
July15911925
August19002256
September21852360
October21002468
November21202480
December21322600

Lupin Share Price Target 2025

Looking for further years then its fundamental is very good the stock has given very good returns in past. Lupin’s market cap is looking strong. The company has very low debt, with a debt-to-equity ratio of 0.20, meaning it has very little debt and could give good returns in the future. Also in recent years, the stock has performed very well. Experts think that in 2025, its share price target would be ₹3240.

In 2025, its share price would be between ₹2200 to ₹3240.

YearMinimum Price (Rs)Maximum Price (Rs)
202522003240
MonthMinimum Price (Rs)Maximum Price (Rs)
January22762784
February22132760
March22502790
April22002848
May22302860
June22572895
July22902964
August23272980
September23003057
October23763122
November23503130
December24133240

Share Price Target 2030

This company has grown fast in India because it makes good medicines that people need. It also provides many heart medicines, which has helped it expand to over 70 countries. As it is a very old company, people trust this company’s products. It has a very strong brand value in the market. Its stock price faced many ups and downs but ultimately for the long-term investors it gave a good profit. It is one of the top companies in the medical sector. For the year 2030, its share price target would be ₹6400.

By 2030, its share price would be between ₹5500 to ₹6400.

YearMinimum Price (Rs)Maximum Price (Rs)
203055006400
MonthMinimum Price (Rs)Maximum Price (Rs)
January55005631
February55675670
March56005700
April55505760
May56405800
June57005930
July58405900
August58906100
September59406173
October60006250
November61236300
December62806400

Share Price Target 2040

As India’s population grows, people are getting sick more often and need more medicine. To meet this demand, the company is expanding its production and opening new branches. The company makes over 180 medicines and is the third-largest drug company in India. On the other hand, The company has given a more than 100% return over the last 5 years. The company could offer very good returns in the future. If the company keeps growing and managing well, it could give very good returns. In 2040, its share price target would be ₹8900.

By 2040, its share price would be between ₹8100 to ₹8900.

YearMinimum Price (Rs)Maximum Price (Rs)
204081008900
MonthMinimum Price (Rs)Maximum Price (Rs)
January81008230
February81858280
March82008346
April82678350
May82908400
June83308450
July83008570
August84508683
September85468712
October86218767
November87158780
December88258900

Share Price Target 2050

The company is known for its quality and genuine pricing. It’s not only known in India but in the foreign country, and its medicine is in high demand. It made medicine for major diseases like heart attacks, mental health, diabetes and so on. At the current time, it is one of the biggest brands in the medical line. The company gained much trust from the people. So in the coming year, its share price will be seen to be on an uptrend. In 2050, its stock price target would be ₹14000.

In 2050, its share price could be between ₹12200 to ₹14000.

YearMinimum Price (Rs)Maximum Price (Rs)
20501220014000
MonthMinimum Price (Rs)Maximum Price (Rs)
January1220012357
February1227012442
March1234012530
April1240012631
May1254012738
June1260912900
July1269013030
August1287513100
September1305613360
October1340013625
November1360013831
December1378014000

Should I Buy Lupin Stock?

YearMinimum Price (Rs)Maximum Price (Rs)
202413002600
202522003240
203055006400
204081008900
20501220014000

The company’s best-selling medicines include drugs for diabetes, infections, heart problems, and asthma. This company also makes and sells brand-name drugs like Lupitac, Metoject, and Lupizole. If you want to invest in a pharma company or are thinking about it, Lupin stock could be a good option for you. In the past year, Lupin stock has gone up by over 100%, making investors very happy.

Lupin Ltd Earning Results

Mcap Full (Cr.)1,02,441.62
Turnover (Cr.)19.43
TTQ (Lakh)0.86
EPS (TTM) 60.06
CEPS (TTM)75.99
PE/PB36.78 / 4.89
ROE13.29
Face Value2.00
NPM %21.34
OPM %29.70
Cash EPS22.60
EPS19.51
Revenue4,167.63
Net Profit889.18

Is Lupin Stock Good to Buy? (Bull case & Bear case)

Bull Case :

  • it is growing well, with new medicines and expanding in global markets.
  • It has shown better sales and profits recently, giving strong returns to investors.
  • There is increasing demand for medicines worldwide, especially for cheaper, generic drugs, which Lupin makes a lot of.

Bear Case :

  • It faces strict rules in different countries. If they fail to meet these rules, they could face fines or bans.
  • There are many other companies making similar medicines.

Conclusion

In this article, we give you all the important information about Lupin. If you are planning to invest in its share or have already invested, this article can be very helpful. We discussed everything from the basics of the company to its future plans and analysis. we have given you the multiple time frame price prediction so please read the whole article to know in depth.

FAQs

The growth of the company is very good. It has very nice fundamentals having very little debt. It gave very good returns in past to its investors. For the long term, you can go for it.

By 2040, its share price would be between ₹8100 to ₹8900.

It does business with foreign countries and it had good sales there.

Similar Stocks